TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANOFI Share Price

Certificat

DE000SN567Y2

Delayed Deutsche Boerse AG 13:26:00 20/06/2024 BST
0.98 EUR +3.16% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANOFI
Current month-25.20%
1 month-23.39%
Date Price Change
20/06/24 0.98 +3.16%
19/06/24 0.95 -11.21%
18/06/24 1.07 +5.94%
17/06/24 1.01 +5.21%
14/06/24 0.96 -11.93%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 01:26 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN SN567Y
ISINDE000SN567Y2
Date issued 11/08/2022
Strike 77.72
Maturity Unlimited
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.9
Lowest since issue 0.4
Spread 0.01
Spread %1.01%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
86.82 EUR
Average target price
108.2 EUR
Spread / Average Target
+24.62%
Consensus